Real-world healthcare resource utilisation for migraine: Analysis of an administrative database in Colombia.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος:	Real-world healthcare resource utilisation for migraine: Analysis of an administrative database in Colombia.
Συγγραφείς:	Sobrino F; Translational Neuroscience Research Lab, Clinical Neurology Program, Universidad de La Sabana, Chía, Colombia; Neurology Unit, Hospital Occidente de Kennedy, Bogotá, Colombia., Zorro M; Medical Department Abbvie Cluster North-LATAM, Bogotá, Colombia. Electronic address: maria.zorro@abbvie.com., Bedoya MT; Medical Department Abbvie Cluster North-LATAM, Bogotá, Colombia., Ramos ML; Hospital Universitario San Ignacio, Bogotá, Colombia.
Πηγή:	Neurologia [Neurologia (Engl Ed)] 2026 Jul-Aug; Vol. 41 (6), pp. 502008. Date of Electronic Publication: 2026 Mar 28.
Τύπος έκδοσης:	Journal Article
Γλώσσα:	English
Στοιχεία περιοδικού:	Publisher: Elsevier España Country of Publication: Spain NLM ID: 101778590 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2173-5808 (Electronic) Linking ISSN: 21735808 NLM ISO Abbreviation: Neurologia (Engl Ed) Subsets: MEDLINE
Imprint Name(s):	Original Publication: [Barcelona] : Elsevier España
Ιατρικοί όροι (MeSH):	Migraine Disorders/epidemiology , Migraine Disorders/economics , Migraine Disorders/therapy , Patient Acceptance of Health Care/statistics & numerical data , Health Resources*, Colombia/epidemiology ; Humans ; Female ; Retrospective Studies ; Male ; Adult ; Health Care Costs ; Prevalence ; Middle Aged ; Databases, Factual ; Incidence ; Adolescent ; Young Adult
Περίληψη:	Introduction: Migraine is a chronic condition characterised by recurrent episodes of severe headache, significantly affecting the functionality of the individuals. The global prevalence and the impact on quality of life highlight the need for research on its epidemiology and management, especially in specific contexts such as Colombia, where information on the subject is scarce. Methods: A retrospective descriptive study was conducted with data from the Information System for Social Protection in Colombia (SISPRO) between 2027 and 2021, evaluating the incidence, prevalence, treatment pattern and cost associated with migraine management. Results: 293 028 incident cases and 1 711 794 prevalent cases of migraine were identified with a higher incidence and prevalence in women. The use of prophylactic treatments and visits to the neurology department showed an increasing trend. Although pharmaceutical costs represented the greatest economic burden, they decreased over the course of the study. The annual healthcare cost per patient, expressed in purchasing power parity (PPP) decreased from $110 PPP in 2017 to a minimum of $39 PPP in 2019. The annual pharmacy cost per patient also dropped from $115 PPP in 2017 to $64 PPP in 2019. Conclusions: This study highlights migraine as a common condition in Colombia, with a prevalence and management that reflect a need for improved educational and treatment strategies. The research also highlights the importance of national data in understanding and addressing this condition, suggesting the need for public health policies focused on the prevention and optimised management of migraine. (Copyright © 2026. Published by Elsevier España, S.L.U.)
Competing Interests:	Declaration of competing interest SF has consulted and given lectures for Abbott, Abbvie, Glaxo, Lily, Merk, Novartis, Pfizer, Procaps, Roche, and Takeda. ZM and BMT are employees of Abbvie and may own stock in Abbvie. RML has given lectures for Abbvie and Novartis.
Contributed Indexing:	Keywords: Colombia; Costos sanitarios; Epidemiology; Epidemiología; Health care costs; Migraine; Migraña; Tratamiento; Treatment
Entry Date(s):	Date Created: 20260330 Date Completed: 20260711 Latest Revision: 20260711
Update Code:	20260712
DOI:	10.1016/j.nrleng.2026.502008
PMID:	41911964
Βάση Δεδομένων:	MEDLINE

View record from ScienceDirect

Περιγραφή
ISSN:	2173-5808
DOI:	10.1016/j.nrleng.2026.502008